Cargando…

WNT Signaling in Melanoma

WNT-signaling controls important cellular processes throughout embryonic development and adult life, so any deregulation of this signaling can result in a wide range of pathologies, including cancer. WNT-signaling is classified into two categories: β-catenin-dependent signaling (canonical pathway) a...

Descripción completa

Detalles Bibliográficos
Autores principales:	Gajos-Michniewicz, Anna, Czyz, Malgorzata
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2020
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7402324/ https://www.ncbi.nlm.nih.gov/pubmed/32659938 http://dx.doi.org/10.3390/ijms21144852

Ejemplares similares

WNT/β-catenin signaling in hepatocellular carcinoma: The aberrant activation, pathogenic roles, and therapeutic opportunities
por: Gajos-Michniewicz, Anna, et al.
Publicado: (2023)

Role of miRNAs in Melanoma Metastasis
por: Gajos-Michniewicz, Anna, et al.
Publicado: (2019)

Pentoxifylline Inhibits WNT Signalling in β-Catenin(high) Patient-Derived Melanoma Cell Populations
por: Talar, Beata, et al.
Publicado: (2016)

MCL-1, BCL-X(L) and MITF Are Diversely Employed in Adaptive Response of Melanoma Cells to Changes in Microenvironment
por: Hartman, Mariusz L., et al.
Publicado: (2015)

Dissecting Mechanisms of Melanoma Resistance to BRAF and MEK Inhibitors Revealed Genetic and Non-Genetic Patient- and Drug-Specific Alterations and Remarkable Phenotypic Plasticity
por: Hartman, Mariusz L., et al.
Publicado: (2020)

Plasticity of Drug-Naïve and Vemurafenib- or Trametinib-Resistant Melanoma Cells in Execution of Differentiation/Pigmentation Program
por: Czyz, Malgorzata, et al.
Publicado: (2019)

Gene Expression Profiling Identifies Microphthalmia-Associated Transcription Factor (MITF) and Dickkopf-1 (DKK1) as Regulators of Microenvironment-Driven Alterations in Melanoma Phenotype
por: Hartman, Mariusz L., et al.
Publicado: (2014)

Histone Deacetylases (HDAC) Inhibitor—Valproic Acid Sensitizes Human Melanoma Cells to Dacarbazine and PARP Inhibitor
por: Drzewiecka, Małgorzata, et al.
Publicado: (2023)

Structural and Biofunctional Insights into the Cyclo(Pro-Pro-Phe-Phe-) Scaffold from Experimental and In Silico Studies: Melanoma and Beyond †
por: Bojarska, Joanna, et al.
Publicado: (2022)

HGF/c-MET Signaling in Melanocytes and Melanoma
por: Czyz, Malgorzata
Publicado: (2018)

PARP1 inhibitor olaparib (Lynparza) exerts synthetic lethal effect against ligase 4-deficient melanomas
por: Czyż, Małgorzata, et al.
Publicado: (2016)

The Functional Role of Long Non-Coding RNAs in Melanoma
por: Wozniak, Michal, et al.
Publicado: (2021)

MITF in melanoma: mechanisms behind its expression and activity
por: Hartman, Mariusz L., et al.
Publicado: (2014)

Inhibitors of HSP90 in melanoma
por: Mielczarek-Lewandowska, Aleksandra, et al.
Publicado: (2019)

Extracellular Vesicles-Based Cell-Cell Communication in Melanoma: New Perspectives in Diagnostics and Therapy
por: Kluszczynska, Katarzyna, et al.
Publicado: (2023)

In the Wnt-er of life: Wnt signalling in melanoma and ageing
por: Kaur, Amanpreet, et al.
Publicado: (2016)

Fibroblast Growth Factor Receptor Signaling in Skin Cancers
por: Czyz, Malgorzata
Publicado: (2019)

Wnt Signaling Pathways: From Inflammation to Non-Melanoma Skin Cancers
por: Di Bartolomeo, Luca, et al.
Publicado: (2023)

Deciphering the Functional Role of RIPK4 in Melanoma
por: Madej, Ewelina, et al.
Publicado: (2021)

lncRNAs-EZH2 interaction as promising therapeutic target in cutaneous melanoma
por: Wozniak, Michal, et al.
Publicado: (2023)

Insulin Reduces the Efficacy of Vemurafenib and Trametinib in Melanoma Cells
por: Osrodek, Marta, et al.
Publicado: (2020)

Physiologically Relevant Oxygen Concentration (6% O(2)) as an Important Component of the Microenvironment Impacting Melanoma Phenotype and Melanoma Response to Targeted Therapeutics In Vitro
por: Osrodek, Marta, et al.
Publicado: (2019)

IGFBP‐3 inhibits Wnt signaling in metastatic melanoma cells
por: Naspi, Antimo, et al.
Publicado: (2016)

WNT Signaling in Disease
por: Ng, Li Fang, et al.
Publicado: (2019)

WNT Signaling in Neuroblastoma
por: Becker, Juergen, et al.
Publicado: (2019)

Wnt signaling in cancer
por: Zhan, T, et al.
Publicado: (2017)

Therapy for BRAFi-Resistant Melanomas: Is WNT5A the Answer?
por: Prasad, Chandra Prakash, et al.
Publicado: (2015)

Parthenolide reduces the frequency of ABCB5-positive cells and clonogenic capacity of melanoma cells from anchorage independent melanospheres
por: Czyz, Malgorzata, et al.
Publicado: (2013)

Wnt Signaling in Bone
por: Kubota, Takuo, et al.
Publicado: (2010)

Natural Compounds' Activity against Cancer Stem-Like or Fast-Cycling Melanoma Cells
por: Sztiller-Sikorska, Malgorzata, et al.
Publicado: (2014)

Wnt Signaling in Gynecologic Malignancies
por: McMellen, Alexandra, et al.
Publicado: (2020)

Wnt signaling in development and disease
por: Yang, Yingzi
Publicado: (2012)

Cilia, Wnt signaling, and the cytoskeleton
por: May-Simera, Helen L, et al.
Publicado: (2012)

Aberrant Wnt Signaling in Leukemia
por: Staal, Frank J. T., et al.
Publicado: (2016)

The function of endocytosis in Wnt signaling
por: Brunt, Lucy, et al.
Publicado: (2017)

Wnt signaling in cervical cancer?
por: Yang, Min, et al.
Publicado: (2018)

RTL1 promotes melanoma proliferation by regulating Wnt/β-catenin signalling
por: Fan, Guobiao, et al.
Publicado: (2017)

Melanoma-Derived Extracellular Vesicles Bear the Potential for the Induction of Antigen-Specific Tolerance
por: Düchler, Markus, et al.
Publicado: (2019)

TYRP1 mRNA level is stable and MITF-M-independent in drug-naïve, vemurafenib- and trametinib-resistant BRAF(V600E) melanoma cells
por: Hartman, Mariusz L., et al.
Publicado: (2019)

Wnt signaling in kidney: the initiator or terminator?
por: Meng, Ping, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_d2b4pkulsh6ebv7ajaml343t64